Effect of Human T-Lymphotropic Virus Type I Infection on Non-Hodgkin's Lymphoma Incidence

Abstract

Studies of HTLV-I carriers known to be infected in childhood may provide insight into markers intermediate in the lympho-magnetic process. Strategies to disrupt early-life transmission of HTLV-I, notably mother-infant transmission, may be critical in reducing the burden of lymphoreticular disease in these populations.